Results 151 to 160 of about 11,719,375 (360)

Development of Specific Dosage Form: Wound Dressing-Current Progress and Novel Approaches. [PDF]

Pharmaceuticals (Basel)
Ghica MV, Kaya MGA, Popa L, Dinu-Pîrvu CE.   +3 more
europepmc   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

Molecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung, David Bickel, Lena C. M. Krause, Daria Ezeriņa, Christian Ickes, Julian Wojtachnia, Christine S. Gibhardt, Magdalena Shumanska, Khadija Wahni, Andrea Paluschkiwitz, Julia Malo Pueyo, Ekaterina Baranova, Wim Vranken, Hedwig Stanisz, Ioana Stejerean‐Todoran, Michael P. Schön, Joris Messens, Ivan Bogeski   +17 more
wiley   +1 more source

From Material to Medicine: Translational Frontiers in Dosage Form Design for Oral Administration. [PDF]

Pharmaceutics
Abdelhakim HE, Awad A.
europepmc   +1 more source

High Performance Liquid Chromatographic Determination of Yohimbine and Strychnine in Dosage Forms

, 1989
Fathalla Belal, Mitsuaki Sano, Isao Tomita   +2 more
openalex   +2 more sources

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

Choosing the "Ideal" Oral Dosage Form for Pediatric Patients: Parents' Perspectives on Children's Preferences with a Focus on Orodispersible Tablets. [PDF]

Children (Basel)
Gvozdeva Y, Staynova R.
europepmc   +1 more source

Soap Dosage Form [PDF]

, 2020
openaire   +1 more source

Rational prescribing and dispensing of oral dosage forms of medicines to children: an observational study [PDF]

Leila Kenzu Kemal, Rahel Belete Abebe, Ashenafi Kibret Sendekie, Tirsit Ketsela Zeleke, Eden Abetu Mehari, Gizework Alemnew Mekonnen, Faisel Dula Sema   +6 more
openalex   +1 more source

APPLICATION OF HIGH-PERFORMANCE THIN-LAYER CHROMATOGRAPHIC METHOD FOR THE SIMULTANEOUS DETERMINATION OF LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE IN PHARMACEUTICAL DOSAGE FORM [PDF]

, 2011
Preeti Chandra, Atul Rathore, Sathiyanarayanan Lohidasan, Kakasaheb Mahadik   +3 more
openalex   +1 more source